- Home
- DV vs XENE Comparison
DV vs XENE Comparison
Compare DV & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DV
- XENE
- Stock Information
- Founded
- DV 2008
- XENE 1996
- Country
- DV United States
- XENE Canada
- Employees
- DV N/A
- XENE N/A
- Industry
- DV Computer Software: Prepackaged Software
- XENE Biotechnology: Pharmaceutical Preparations
- Sector
- DV Technology
- XENE Health Care
- Exchange
- DV Nasdaq
- XENE Nasdaq
- Market Cap
- DV 2.2B
- XENE 2.5B
- IPO Year
- DV 2021
- XENE 2014
- Fundamental
- Price
- DV $12.48
- XENE $35.11
- Analyst Decision
- DV Buy
- XENE Strong Buy
- Analyst Count
- DV 19
- XENE 8
- Target Price
- DV $20.42
- XENE $56.38
- AVG Volume (30 Days)
- DV 2.6M
- XENE 870.9K
- Earning Date
- DV 05-08-2025
- XENE 05-08-2025
- Dividend Yield
- DV N/A
- XENE N/A
- EPS Growth
- DV N/A
- XENE N/A
- EPS
- DV 0.32
- XENE N/A
- Revenue
- DV $656,849,000.00
- XENE N/A
- Revenue This Year
- DV $13.24
- XENE N/A
- Revenue Next Year
- DV $12.97
- XENE $1,553.36
- P/E Ratio
- DV $39.00
- XENE N/A
- Revenue Growth
- DV 14.72
- XENE N/A
- 52 Week Low
- DV $11.52
- XENE $26.74
- 52 Week High
- DV $31.15
- XENE $46.00
- Technical
- Relative Strength Index (RSI)
- DV 37.80
- XENE 55.88
- Support Level
- DV $11.86
- XENE $32.35
- Resistance Level
- DV $12.97
- XENE $34.08
- Average True Range (ATR)
- DV 0.73
- XENE 2.43
- MACD
- DV 0.14
- XENE 0.57
- Stochastic Oscillator
- DV 46.72
- XENE 96.54
About DV DoubleVerify Holdings Inc.
DoubleVerify Holdings Inc is a digital media measurement and analytics software platform. Its solutions provide advertisers with unbiased data analytics that enable them to increase the effectiveness, quality, and return on their digital advertising investments. Its DV Authentic Ad, a proprietary metric of digital media quality, measures whether a digital ad was delivered in a brand-suitable environment, fully viewable, by a real person, and in the intended geography. The company's software interface, DV Pinnacle, delivers these metrics to customers in real time, allowing them to access critical performance data on their digital transactions. Geographically, the company operates in the United States and also has a presence in Germany, Singapore, France, Canada, Japan, and other countries.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.